Pharmacogenetic landscape of epidermal growth factor receptor mutations in Kurdish non-small cell lung cancer patients: implications for precision oncology.

Hamad BK, Omar SS, Alnaqshabandy IHF, Tawfeeq RD, Abdullah SA, Jalal AR

Open source

DOI
10.3332/ecancer.2026.2087
Published
2026
Container
Ecancermedicalscience
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3332/ecancer.2026.2087,
  title = {Pharmacogenetic landscape of epidermal growth factor receptor mutations in Kurdish non-small cell lung cancer patients: implications for precision oncology.},
  author = {Hamad BK and Omar SS and Alnaqshabandy IHF and Tawfeeq RD and Abdullah SA and Jalal AR},
  year = {2026},
  journal = {Ecancermedicalscience},
  doi = {10.3332/ecancer.2026.2087},
  url = {https://doi.org/10.3332/ecancer.2026.2087}
}

RIS

TY  - JOUR
TI  - Pharmacogenetic landscape of epidermal growth factor receptor mutations in Kurdish non-small cell lung cancer patients: implications for precision oncology.
AU  - Hamad BK
AU  - Omar SS
AU  - Alnaqshabandy IHF
AU  - Tawfeeq RD
AU  - Abdullah SA
AU  - Jalal AR
PY  - 2026
JO  - Ecancermedicalscience
DO  - 10.3332/ecancer.2026.2087
UR  - https://doi.org/10.3332/ecancer.2026.2087
ER  - 

APA

BK, H., SS, O., IHF, A., RD, T., SA, A., & AR, J. (2026). Pharmacogenetic landscape of epidermal growth factor receptor mutations in Kurdish non-small cell lung cancer patients: implications for precision oncology.. Ecancermedicalscience. https://doi.org/10.3332/ecancer.2026.2087

Source records